New late-breaking data for Nektar Therapeutics' lead drug candidate, rezpegaldesleukin, suggests systemic anti-inflammatory benefits in patients with comorbid asthma, potentially expanding its market reach and strengthening the investment case for the biopharma firm.
Brazil's state-controlled oil giant Petrobras is trading at deep value multiples, offering investors a covered dividend yield near 10%. Analysts argue its disciplined payout and exposure to a tightening global oil market create a rare mix of income and asymmetric upside.
As TTM Technologies prepares to release its quarterly results, analysts anticipate sustained revenue growth and robust performance in the competitive PCB manufacturing sector.
Global equities and commodities staged a broad recovery on Tuesday, shaking off a pan-Asian rout triggered by a hawkish Fed nominee and geopolitical jitters. The rebound was anchored by surprisingly strong US manufacturing figures, offering a respite to bruised investors.
French biotech Abivax sees renewed investor interest following strong Phase 3 data for its oral therapy obefazimod in hard-to-treat ulcerative colitis, with analysts pointing to a clear path to regulatory approval and significant market potential.
The NAND flash memory specialist's stock skyrocketed last month, propelled by surging prices and blockbuster earnings that smashed Wall Street estimates, highlighting its pivotal role in the AI infrastructure build-out.
Cloud provider CoreWeave faces investor lawsuits over capacity claims just as Nvidia doubles down with a major investment, placing the company at the center of a high-stakes debate on AI infrastructure's future.
Over 247,000 residential customers of Potomac Edison, a FirstEnergy subsidiary in Maryland, will see automatic credits on their utility bills this month. The move, part of a state-mandated relief program, underscores the delicate balance utilities must strike between regulatory compliance, infrastructure investment, and consumer affordability pressures.
Greg Abel's first major move as Berkshire Hathaway CEO involves reviewing a full exit from the Kraft Heinz stake, marking a potential departure from Warren Buffett's famed 'buy and hold' philosophy and testing investor confidence in the new leadership era.
Johnson & Johnson's oncology portfolio gains momentum with new clinical data for prostate cancer drug Erleada and a broader FDA label for multiple myeloma therapy Darzalex Faspro, reinforcing its competitive stance in key cancer markets.
As hyperscalers like Amazon prepare to report earnings, the focus is shifting from quarterly sales to massive capital investments in AI infrastructure and strategic partnerships with GPU-as-a-service providers.
The swearing-in of Rep. Christian Menefee (D-Texas) on Monday tightens the House margin to 218-214, leaving Speaker Mike Johnson with virtually no room for error on key votes, starting with this week's critical government funding bill.
Personal finance expert Dave Ramsey joins critics in dismissing the concept of a 50-year home loan, arguing it offers minimal monthly savings while drastically increasing long-term costs and risks for homeowners.
ResMed Inc., the sleep therapy giant, faces a pivotal moment. While benefiting from a competitor's recall and a growing market funnel, emerging oral treatments and shifting dynamics pose fresh challenges to its long-held CPAP business model.
Despite a sharp selloff following strong quarterly results, Zscaler's fundamental growth engine—fueled by its Z-Flex platform shift and AI security demand—appears stronger than ever, presenting a potential disconnect for long-term investors.
As the AI infrastructure race intensifies, a critical bottleneck is emerging: memory. With demand for high-bandwidth memory (HBM) skyrocketing, Micron Technology finds itself at the center of a new investment thesis, drawing comparisons to the early days of Nvidia's AI-driven ascent.
A Virginia jury has found former federal agent Brendan Banfield guilty of orchestrating the murders of his wife and an innocent man, a scheme prosecutors say was designed to frame the victim and allow Banfield to continue an affair with the family's live-in nanny.
Shares of Malaysian bottled water leader Spritzer Bhd have jumped nearly 10% in a month, outpacing the broader market. Analysts point to the company's robust return on equity and consistent profit reinvestment as key drivers behind investor confidence and its impressive earnings growth trajectory.
Amid market volatility, investors hunting for durable passive income are turning to proven dividend payers. Chevron and Kimberly-Clark, with their long histories and robust cash flows, offer compelling high-yield opportunities despite sector-specific challenges.
The company's 713,502 BTC hoard, now valued at its average purchase price, has transformed from a corporate treasury strategy into a critical technical level that could dictate broader market movements.
